Insider · CIK 0001351888

Reich Siegfried

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001351888

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-02-09	Turning Point Therapeutics, Inc.S Sale	EVP & Chief Scientific Officer	SSale	−397 sh	$36.30	−$14.4K	3,448
2022-02-09	Turning Point Therapeutics, Inc.A Award	EVP & Chief Scientific Officer	AAward	+13.6K sh	—	—	17,015
2022-02-09	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	EVP & Chief Scientific Officer	AAward	+48.8K sh	—	—	48,833
2021-03-04	Turning Point Therapeutics, Inc.M Exercise/Conversion	EVP & Chief Scientific Officer	MExercise/Conversion	+35.6K sh	$51.28	+$1.82M	39,395
2021-03-04	Turning Point Therapeutics, Inc.S Sale	EVP & Chief Scientific Officer	SSale	−3,005 sh	$102.01	−$307K	36,390
2021-03-04	Turning Point Therapeutics, Inc.S Sale	EVP & Chief Scientific Officer	SSale	−8,820 sh	$102.87	−$907K	27,570
2021-03-04	Turning Point Therapeutics, Inc.S Sale	EVP & Chief Scientific Officer	SSale	−6,220 sh	$103.65	−$645K	21,350
2021-03-04	Turning Point Therapeutics, Inc.S Sale	EVP & Chief Scientific Officer	SSale	−2,000 sh	$104.97	−$210K	19,350
2021-03-04	Turning Point Therapeutics, Inc.S Sale	EVP & Chief Scientific Officer	SSale	−3,103 sh	$105.71	−$328K	16,247
2021-03-04	Turning Point Therapeutics, Inc.S Sale	EVP & Chief Scientific Officer	SSale	−6,716 sh	$107.13	−$719K	9,531
2021-03-04	Turning Point Therapeutics, Inc.S Sale	EVP & Chief Scientific Officer	SSale	−3,679 sh	$107.85	−$397K	5,852
2021-03-04	Turning Point Therapeutics, Inc.S Sale	EVP & Chief Scientific Officer	SSale	−707 sh	$108.92	−$77K	5,145
2021-03-04	Turning Point Therapeutics, Inc.S Sale	EVP & Chief Scientific Officer	SSale	−700 sh	$110.59	−$77.4K	4,445
2021-03-04	Turning Point Therapeutics, Inc.S Sale	EVP & Chief Scientific Officer	SSale	−600 sh	$111.46	−$66.9K	3,845
2021-03-04	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Scientific Officer	MExercise/Conversion	−35.6K sh	—	—	114,450
2021-02-08	Turning Point Therapeutics, Inc.A Award	EVP & Chief Scientific Officer	AAward	+3,845 sh	—	—	3,845
2021-02-08	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	EVP & Chief Scientific Officer	AAward	+17.3K sh	—	—	17,303
2020-03-02	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	EVP & Chief Scientific Officer	AAward	+150K sh	—	—	150,000
2007-09-17	SGX PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Drug Discovery	MExercise/Conversion	+1,563 sh	—	—	16,408
2007-09-17	SGX PHARMACEUTICALS, INC.S Sale	VP, Drug Discovery	SSale	−781 sh	$6.20	−$4,842.2	15,627
2007-09-17	SGX PHARMACEUTICALS, INC.Restricted Stock UnitsM Exercise/Conversion	VP, Drug Discovery	MExercise/Conversion	−1,563 sh	—	—	43,750
2007-08-15	SGX PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Drug Discovery	MExercise/Conversion	+1,562 sh	—	—	15,626
2007-08-15	SGX PHARMACEUTICALS, INC.S Sale	VP, Drug Discovery	SSale	−669 sh	$6.40	−$4,281.6	14,957
2007-08-15	SGX PHARMACEUTICALS, INC.S Sale	VP, Drug Discovery	SSale	−112 sh	$6.45	−$722.4	14,845
2007-08-15	SGX PHARMACEUTICALS, INC.Restricted Stock UnitsM Exercise/Conversion	VP, Drug Discovery	MExercise/Conversion	−1,562 sh	—	—	45,313
2007-06-15	SGX PHARMACEUTICALS, INC.M Exercise/Conversion	VP, Drug Discovery	MExercise/Conversion	+1,562 sh	—	—	14,063
2007-06-15	SGX PHARMACEUTICALS, INC.S Sale	VP, Drug Discovery	SSale	−581 sh	$5.11	−$2,968.91	13,482
2007-06-15	SGX PHARMACEUTICALS, INC.S Sale	VP, Drug Discovery	SSale	−100 sh	$5.15	−$515	13,382
2007-06-15	SGX PHARMACEUTICALS, INC.S Sale	VP, Drug Discovery	SSale	−100 sh	$5.18	−$518	13,282
2007-06-15	SGX PHARMACEUTICALS, INC.Restricted Stock UnitsM Exercise/Conversion	VP, Drug Discovery	MExercise/Conversion	−1,562 sh	—	—	48,438

Recent filings

Accepted (ET)
Feb 114
Reich Siegfried0001209191-22-008984
SEC(opens sec.gov)
Mar 54
Reich Siegfried0001209191-21-018435
SEC(opens sec.gov)
Feb 104
Reich Siegfried0001209191-21-009364
SEC(opens sec.gov)
Mar 24
Reich Siegfried0001209191-20-014800
SEC(opens sec.gov)
Sep 174
SGX PHARMACEUTICALS, INC.0001351888-07-000017
SEC(opens sec.gov)

Companies

Address

C/O TURNING POINT THERAPEUTICS, INC. 10628 SCIENCE CENTER DRIVE, STE. 200

SAN DIEGO, CA, 92121